Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.76
(
1.11%
)
Bitcoin
71,459.32
(
0.30%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 148109

Monday, 10/27/2014 9:31:47 AM

Monday, October 27, 2014 9:31:47 AM

Post# of 257257
AGN’s CEO David Pyott didn’t miss an opportunity to blast VRX on today's CC by noting that the Restylane/Perlane/Sculptra franchise of dermal fillers has stabilized after VRX sold it to Nestle/Galderma (#msg-102583917) after it had steadily lost market share while owned by VRX.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today